Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 89   

Articles published

ATOS 0.481 +0.022 (4.72%)
price chart
Atossa Genetics Inc. to Raise Approximately $6220000 From Institutional ...
Company Contact Steven C. Quay, M.D., Ph.D. President & Chief Executive Officer Atossa Genetics Inc. Phone: (800) 351-3902 and Kyle Guse Chief Financial Officer, General Counsel and Secretary Atossa Genetics Inc. Phone: (800) 351-3902 Investor ...
Atossa Genetics (ATOS) Announces $6.22 Common Stock, Warrants Direct Placement
Price Target Update on Atossa Genetics Inc. (NASDAQ:ATOS)
Atossa Genetics Inc. (NASDAQ:ATOS): 2 analysts have set the short term price target of Atossa Genetics Inc. (NASDAQ:ATOS) at $4.75.
Atossa Genetics Inc. (NASDAQ:ATOS) Price Target Update
Atossa Genetics Inc. (NASDAQ:ATOS) stock has received a short term price target of $ 7 from 2 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $2.83.
Company Shares of Atossa Genetics Inc. (NASDAQ:ATOS) Drops by -8.81%
Atossa Genetics Inc. (NASDAQ:ATOS) has lost 8.81% during the past week and dropped 21.53% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 5.38%.
Atossa Genetics (ATOS) Stock Declines Today on Heavy Trading Volume
"We rate ATOSSA GENETICS INC (ATOS) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the ...
Related articles »  
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
Atossa Genetics (NASDAQ:ATOS) went up over 40% in early trading when it announced Henry Schein will offer Atossa Genetics' FullCYTE Breast Aspirator on Feb 26th, 2015. Traders and investors have been repetitively trapped by this type of trivial news ...
After Forming Bearish Wedge Down, Is Atossa Genetics Inc's Near-Term Analysis ...
The stock of Atossa Genetics Inc (ATOS) formed a down wedge with $0.45 target or 14.00% below today's $0.52 share price.
Atossa Genetics Inc. (ATOS) Adopts Poison Pill Provision
Atossa Genetics Inc. (Nasdaq: ATOS) announced that its Board of Directors has approved the adoption of a stockholder rights agreement.
Related articles »  
Atossa Genetics Announces Third Quarter 2015 Financial Results and Provides ...
Atossa Genetics, Inc. (NASDAQ: ATOS) today announced third quarter 2015 financial results and provided an update on recent company developments.
Atossa Genetics (ATOS) Issues Earnings Results  Dakota Financial News
Atossa Genetics (ATOS) Announces Earnings Results  Intercooler
Company Shares of Atossa Genetics Inc. (NASDAQ:ATOS) Rally 2.61%
Shares of Atossa Genetics Inc. (NASDAQ:ATOS) appreciated by 2.61% during the past week but lost 3.66% on a 4-week basis. The shares have outperformed the S&P 500 by 1.69% in the past week but underperformed the index by 7.22% in the last 4 weeks.
Monday Morning Thoughts: Atossa Genetics, Inc. (ATOS), Civitas Solutions ...  WallStreet Scope